SCHEMBL760303

SCHEMBL760303

O=C(c1ccccc1)C(CCl)CCl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.52
ALDH1A1 P00352 3/20 0.52
HIF1A Q16665 2/20 0.52
GSK3B P49841 2/20 0.52
TRPA1 O75762 1/20 0.52
MAPT P10636 4/20 0.52
RAB9A P51151 3/20 0.52
ATM Q13315 3/20 0.52
NPC1 O15118 2/20 0.52
HTT P42858 2/20 0.52
TDP1 Q9NUW8 3/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
MDM2 Q00987 1/20 0.50
CES1 P23141 4/20 0.48
CES2 O00748 3/20 0.48
LMNA P02545 2/20 0.48
TSHR P16473 3/20 0.47
ALKBH5 Q6P6C2 1/20 0.46
PGR P06401 1/20 0.46
ADRA2A P08913 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18658544 0.85 MAPK1 (0.51) MAPK1ALDH1A1HIF1AGSK3BTRPA1
SCHEMBL7722849 0.83 RAB9A (0.46) MAPK1ALDH1A1HIF1AGSK3BTRPA1
SCHEMBL22856975 0.83 MAPK1 (0.46) MAPK1ALDH1A1HIF1AGSK3BTRPA1
SCHEMBL6937095 0.82 MMP2 (0.50) MAPK1ALDH1A1MAPTRAB9AATM
SCHEMBL3319972 0.80 CES1 (0.52) MAPK1ALDH1A1HIF1AGSK3BTRPA1
SCHEMBL3319973 0.80 CES1 (0.52) MAPK1ALDH1A1HIF1AGSK3BTRPA1
SCHEMBL5952562 0.80 MAPK1 (0.50) MAPK1ALDH1A1HIF1AGSK3BTRPA1
SCHEMBL3323928 0.80 CES1 (0.52) MAPK1ALDH1A1HIF1AGSK3BTRPA1
SCHEMBL9350244 0.79 MAPT (0.53) MAPK1ALDH1A1HIF1AGSK3BTRPA1
SCHEMBL8898354 0.78 MAPK1 (0.48) MAPK1ALDH1A1HIF1AGSK3BTRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025096858-A1 COMPOUNDS FOR THE DEGRADATION OF MUTANT BRAF C4 THERAPEUTICS, INC. (US) 2025-05-08 WO disclosed
EP-3468977-B1 FXR (NR1H4) MODULATING COMPOUNDS GILEAD SCIENCES INC (US) 2021-07-21 EP disclosed
EP-3468977-B1 FXR (NR1H4) MODULATING COMPOUNDS GILEAD SCIENCES INC (US) 2021-07-21 EP disclosed
EP-3233850-B1 HYDROXY CONTAINING FXR (NR1H4) MODULATING COMPOUNDS GILEAD SCIENCES INC (US) 2019-04-03 EP disclosed
US-9932332-B2 FXR (NR1H4) modulating compounds GILEAD SCIENCES, INC. (US) 2018-04-03 US disclosed
US-9932332-B2 FXR (NR1H4) modulating compounds GILEAD SCIENCES, INC. (US) 2018-04-03 US disclosed
WO-2017218379-A1 FXR (NR1H4) MODULATING COMPOUNDS GILEAD SCIENCES, INC. (US) 2017-12-21 WO disclosed
US-20170355694-A1 FXR (NR1H4) MODULATING COMPOUNDS PHENEX PHARMACEUTICALS AG (DE) 2017-12-14 US disclosed
US-20170355694-A1 FXR (NR1H4) MODULATING COMPOUNDS PHENEX PHARMACEUTICALS AG (DE) 2017-12-14 US disclosed
US-20170355694-A1 FXR (NR1H4) MODULATING COMPOUNDS PHENEX PHARMACEUTICALS AG (DE) 2017-12-14 US disclosed
US-20080176947-A1 Heterocyclic-Substituted Alkanamides Useful as Renin Inhibitors NOVARTIS AG (CH) 2008-07-24 US disclosed
EP-1856032-A1 HETEROCYCLIC-SUBSTITUTED ALKANAMIDES USEFUL AS RENIN INHIBITORS Speedel Experimenta AG (CH) 2007-11-21 EP disclosed
WO-2007069777-A2 FUNGICIDAL COMPOSITION CONTAINING CARBOXYLIC ACID AMIDE DERIVATIVE ISHIHARA SANGYO KAISHA, LTD. (JP) 2007-06-21 WO disclosed
EP-1776011-A1 FUNGICIDAL COMPOSITION CONTAINING ACID AMIDE DERIVATIVE ISHIHARA SANGYO KAISHA, LTD. (JP) 2007-04-25 EP disclosed
WO-2007031558-A1 5-AMINO-4-HYDROXY-7- (IMIDAZO [1,2-A] PYRIDIN-6- YLMETHYL)-8-METHYL-NONAMIDE DERIVATIVES AND RELATED COMPOUNDS AS RENIN INHIBITORS FOR THE TREATMENT OF HYPERTENSION SPEEDEL EXPERIMENTA AG (CH) 2007-03-22 WO disclosed
US-20060217534-A1 Bis (amino acid) molecular scaffolds UNIVERSITY OF PITTSBURGH OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2006-09-28 US disclosed
WO-2006095020-A1 HETEROCYCLIC-SUBSTITUTED ALKANAMIDES USEFUL AS RENIN INHIBITORS SPEEDEL EXPERIMENTA AG (CH) 2006-09-14 WO disclosed
WO-2006016708-A1 FUNGICIDAL COMPOSITION CONTAINING ACID AMIDE DERIVATIVE ISHIHARA SANGYO KAISHA, LTD. (JP) 2006-02-16 WO disclosed
US-20040077879-A1 Bis (amino acid) molecular scaffolds UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2004-04-22 US disclosed
US-4035395-A Process for the preparation of ketones BAYER AKTIENGESELLSCHAFT (DT) 1977-07-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170355694-A1 FXR (NR1H4) MODULATING COMPOUNDS NR1H4, NR1H2, NR1H3 MAPK1 1984/4885ALDH1A1 3805/4885HIF1A 3369/4885
US-20040077879-A1 Bis (amino acid) molecular scaffolds DNPEP, BCAT1, BCAT2 MAPK1 3621/4885ALDH1A1 3893/4885HIF1A 2993/4885
US-20080176947-A1 Heterocyclic-Substituted Alkanamides Useful as Renin Inhibitors REN, ACE, AGTR1 MAPK1 487/4885ALDH1A1 146/4885HIF1A 2279/4885
US-20060217534-A1 Bis (amino acid) molecular scaffolds DNPEP, BCAT1, BCAT2 MAPK1 3621/4885ALDH1A1 3893/4885HIF1A 2993/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.